Evidence map›Paper›PMID 40918758›Full record

ArticleCureus2025

Severe Vaping Product Use‑Associated Lung Injury in a Healthy Young Adult: A Case Report.

Nouf A Al Alhadi, Abdulrahman K Alamer, Rawan H Albalawi, Anas E Ahmed

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nouf A Al AlhadiInternal Medicine, King Fahad Central Hospital, Jazan, SAU.
Abdulrahman K AlamerCollege of Medicie, King Faisal University, AlAhsa, SAU.
Rawan H AlbalawiFaculty of Medicine, Tabuk University, Tabuk, SAU.
Anas E AhmedCommunity Medicine, Jazan University, Riyadh, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaping product use-associated lung injury is a recently recognized respiratory illness that can occur in users of e-cigarettes or vaping products, including those marketed as nicotine‑free. We describe a previously healthy, 22‑year‑old male, non‑smoker who presented with progressive shortness of breath, non‑productive cough, pleuritic chest pain, low‑grade fever, and fatigue. He reported daily use of a flavored nicotine‑free vaping device for eight months, with increased use in the preceding month, including cartridges purchased from unregulated online sources. Examination revealed hypoxemia, tachypnea, and diffuse inspiratory crackles. Laboratory studies showed leukocytosis and elevated inflammatory markers, while infectious and autoimmune evaluations were negative. High‑resolution computed tomography demonstrated bilateral ground‑glass opacities with dependent predominance and subpleural sparing. A presumptive diagnosis of vaping product use-associated lung injury was made. The patient improved rapidly with supplemental oxygen and corticosteroid therapy, and at the three‑month follow‑up, he had complete symptom resolution, normal pulmonary function, and near‑complete radiographic recovery. This case highlights that severe lung injury can occur in healthy young adults using nicotine‑free vaping products from informal sources, emphasizing the need for thorough vaping histories, careful exclusion of alternative diagnoses, and public health interventions to regulate product safety.

Indexed as

acute hypoxemic respiratory failurecorticosteroid therapye‑cigaretteground‑glass opacitieslung injurynicotine‑free vapingpublic healthvapingvaping product use‑associated lung injury

Identifiers

PMID40918758
PMCPMC12413020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.